[go: up one dir, main page]

AR049518A1 - Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados - Google Patents

Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados

Info

Publication number
AR049518A1
AR049518A1 ARP050102466A ARP050102466A AR049518A1 AR 049518 A1 AR049518 A1 AR 049518A1 AR P050102466 A ARP050102466 A AR P050102466A AR P050102466 A ARP050102466 A AR P050102466A AR 049518 A1 AR049518 A1 AR 049518A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
composition including
active principles
silicone agent
solubilized active
Prior art date
Application number
ARP050102466A
Other languages
English (en)
Inventor
Leslie Zanutto
Sandrine Orsoni
Emilie Tonglet
Claire Mallard
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of AR049518A1 publication Critical patent/AR049518A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion farmacéutica estable, anhidra, que comprende un agente siliconado que comprende, al menos, un elastomero organopoli-siloxano y a título de principios activos, vitamina D o un derivado de la vitamina D y un corticosteroide, a su procedimiento de preparacion, y a su utilizacion para el tratamiento topico de la psoriasis y otras afecciones cutáneas.
ARP050102466A 2004-06-17 2005-06-16 Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados AR049518A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0406610A FR2871695B1 (fr) 2004-06-17 2004-06-17 Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises

Publications (1)

Publication Number Publication Date
AR049518A1 true AR049518A1 (es) 2006-08-09

Family

ID=34948706

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050102466A AR049518A1 (es) 2004-06-17 2005-06-16 Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados

Country Status (7)

Country Link
US (1) US7901698B2 (es)
CN (1) CN1968701A (es)
AR (1) AR049518A1 (es)
FR (1) FR2871695B1 (es)
MX (1) MXPA06014300A (es)
RU (1) RU2007101511A (es)
ZA (1) ZA200700304B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
PL2526930T3 (pl) * 2005-06-01 2014-05-30 Glaxosmithkline Ip Dev Ltd Formulacja witaminowa
US20080153786A1 (en) * 2006-05-22 2008-06-26 Galderma S.A. Controlled release of drugs into/through the skin
FR2887150B1 (fr) * 2005-06-17 2007-08-03 Galderma Res & Dev Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
US20100056644A1 (en) * 2006-11-29 2010-03-04 Nilendu Sen Pharmaceutical compositions containing anhydrous calcipotriene
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
US9481646B2 (en) * 2007-04-18 2016-11-01 The Johns Hopkins University Low calcemic, highly antiproliferative, analogs of calcitriol
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US20090175810A1 (en) * 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
HRP20191711T1 (hr) 2011-03-14 2019-12-13 Drug Delivery Solutions Ltd Oftalmološki pripravak
CA2834301A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Treatment of psoriasis
EP2796149A4 (en) * 2011-12-21 2015-07-15 Maruho Kk SKIN COMPOSITION CONTAINING SILICONE BASE
US20140107223A1 (en) * 2012-10-12 2014-04-17 Whitehill Oral Technologies, Inc. Topical ubiquinol supplement skin care compositions
TWI503279B (zh) * 2013-01-09 2015-10-11 Univ Nat Cheng Kung Silica gel composition and preparation method thereof
JP6856631B2 (ja) 2015-09-16 2021-04-07 ディーエフビー ソリア リミテッド ライアビリティ カンパニー 薬物ナノ粒子の送達およびその使用法
US20180000836A1 (en) * 2016-07-01 2018-01-04 Yousif Kattoula Topical Treatment for Psoriasis
CA3056395C (en) 2017-03-15 2022-06-28 Dfb Soria, Llc Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
US11497726B2 (en) 2018-03-16 2022-11-15 Dfb Soria, Ll. Topical therapy for the treatment of cervical intraepithelial neoplasia (CIN) and cervical cancer using nanoparticles of taxanes
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
US20210346471A1 (en) * 2020-04-30 2021-11-11 Danny C Purser Superoxide dismutase compositions and methods
RU2742411C1 (ru) * 2020-10-08 2021-02-05 Георгий Сергеевич Немов Противопсориатическая косметическая композиция в виде геля

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308264A (en) * 1981-01-28 1981-12-29 Abbott Laboratories Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US5254334A (en) * 1992-05-04 1993-10-19 Imaginative Research Associates, Inc. Anhydrous foaming composition containing low concentrations of detergents and high levels of glycerin amd emollients such as oils and esters
FR2719220A1 (fr) * 1994-04-29 1995-11-03 Lafon Labor Nouvelle forme galénique pour l'administration transdermique.
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
FR2738745B1 (fr) * 1995-09-15 1997-10-24 Cird Galderma Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations
IT1302275B1 (it) * 1998-09-25 2000-09-05 Giorgio Panin Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica.
SI3146969T1 (en) * 1999-04-23 2018-08-31 Leo Pharma A/S Ointment for topical treatment of psoriasis
DE10024413A1 (de) * 2000-05-19 2001-12-06 Mika Pharma Gmbh Pharmazeutische und/oder kosmetische Zubereitung
US20020018791A1 (en) * 2000-07-10 2002-02-14 Vatter Michael Lee Anhydrous cosmetic compositions
US20030091522A1 (en) * 2001-08-24 2003-05-15 Collins Carol J. Reduced-wax mascara compositions
US20070190124A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs

Also Published As

Publication number Publication date
US7901698B2 (en) 2011-03-08
FR2871695B1 (fr) 2008-07-04
US20050282788A1 (en) 2005-12-22
MXPA06014300A (es) 2007-02-19
CN1968701A (zh) 2007-05-23
ZA200700304B (en) 2007-12-27
FR2871695A1 (fr) 2005-12-23
RU2007101511A (ru) 2008-07-27

Similar Documents

Publication Publication Date Title
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
CU23423B7 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulación sanguínea
CR10838A (es) Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
BRPI0507198A (pt) derivados de bisariluréia
CL2007003356A1 (es) Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades.
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
CO5640037A2 (es) Derivados de la quinazolina para el tratamiento del cancer
BR112012015433B8 (pt) composição farmacêutica substancialmente anidra para aplicação cutânea
AR109263A2 (es) Composición que comprende moxidectina
EA200702204A1 (ru) Лечение заболеваний соединительной ткани кожи
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
MX2009011900A (es) Curacion de herida diabetica.
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
AR046146A1 (es) Formulaciones farmaceuticas transdermicas para pulverizacion que comprenden un agente activo, un copolimero de vp/va y un vehiculo no acuoso
FR2887150B1 (fr) Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
BRPI0511398A (pt) composição farmacêutica anidra para o tratamento da psorìase e uso de um agente siliconado
MXPA06012206A (es) Composicion farmaceutica ozonizada y metodos.
CL2008002465A1 (es) Composición farmacéutica anhidra tópica, que comprende derivados de niacina y un portador aceptable, su aplicacón permite un bienestar sexual mejorado.
BRPI0607976A2 (pt) composição farmacêutica e uso de uma composição
BRPI0602179A (pt) composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação

Legal Events

Date Code Title Description
FB Suspension of granting procedure